Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Merck & Co. Q1 adj. profit rises, beats estimates
Merck & Co. Inc. (NYSE: MRK) Thursday reported an increase in adjusted earnings for the first quarter of 2025, while the pharma company’s sales declined modestly.
First-quarter sales were $15.5 billion, compared to $15.8 billion in the prior year quarter. Pharmaceutical sales declined by 3% while Animal Health sales grew by 5%.
The company reported adjusted earnings of $2.22 per share for the first quarter, compared to $2.07 per share in Q1 2024. The latest number topped expectations. Net profit was $5.08 billion or $2.01 per share in the March quarter, compared to $4.76 billion or $1.87 per share in the same period of last year.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
